Abstract: The disclosure discloses a power module. The power module includes a substrate, a power chip, a bonding material, and at least one spacer. The substrate includes a circuit-patterned layer. The power chip bonded to the circuit-patterned layer by the bonding material. The spacer is located between the circuit-patterned layer and the power chip, so as to keep the power chip away from the circuit-patterned layer in a distance.

Abstract: The disclosure relates to a display panel, a method for fabricating the same, and a display device. The display panel includes: a base substrate, and a thin film transistor structure, an anode layer, a light-emitting layer, a cathode layer, and an encapsulation layer, which are arranged successively on the base substrate, wherein at least one installation hole for installing a hardware structure is arranged in a display area of the display panel, and the installation hole runs through the base substrate and the respective layers on the display panel in the direction perpendicular to the base substrate; and the edge of the installation hole is arranged with an encapsulation layer material, and the encapsulation layer material covers at least the light-emitting layer and the cathode layer adjacent to the edge of the installation hole, in the direction parallel to the base substrate.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: A method for making artificial graphite includes placing a graphene film on a surface of a base, to obtain a graphene film/base composite structure. The graphene film includes a first surface and a second surface opposite to the first surface, and the second surface is in direct contact with the surface of the base. The graphene film/base composite structure is placed in a reaction chamber, and a carbon layer is formed on the first surface of the graphene film, to obtain a carbon layer/graphene film/base composite structure. The carbon layer/graphene film/base composite structure is graphitized in an inert gas environment or a vacuum environment to obtain artificial graphite.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R1 does not exist; W is C or N with the proviso that when W is N, R2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C1-C6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: A composition of goserelin sustained release microspheres is provided. The microspheres comprise goserelin, at least one poly (lactide-co-glycolide) and poloxamer or PEG. The sustained release microspheres have comparatively high bioavailability, which promotes the drug taking its full effect and have entrapment efficiency over 90%.

Abstract: The present disclosure discloses a hologram recording device and a hologram recording method. The hologram recording device comprises an object imaging unit comprising a cavity for accommodating an object whose interior wall is a reflective surface, and a light modulating unit configured to produce incident light and reference light interfering with the incident light and to direct the incident light to the object imaging unit. The cavity is provided with an imaging aperture for imaging of the object and at least one light incidence aperture for allowing the incident light to enter the cavity and irradiate on the object, such that an image of the object is formed at a location corresponding to the imaging aperture outside the cavity, and image light produced upon the imaging of the object interferes with the reference light at the location for recording of an image surface hologram.

Abstract: An electrostatic sensing device comprises an electrostatic sensing module and a control unit electrically connected to the electrostatic sensing module. The electrostatic sensing module comprises a first electrostatic sensing element comprising opposite ends, and two first electrodes. The two first electrodes are separately located on and electrically connected to the two opposite ends of the first electrostatic sensing element. The first electrostatic sensing element is one-dimensional semiconducting linear structure with a diameter less than 100 nanometers. The control unit electrically is configured to apply a direct voltage to the first electrostatic sensing element and measure a current/resistance of the first electrostatic sensing element.

Abstract: A touch and hover sensing device includes a sensing module, a hover sensing unit, a touch sensing unit, and a switching control unit switching between a hover mode and a touch mode. The sensing module includes a plurality of first electrostatic sensing elements and a plurality of second electrostatic sensing elements electrically insulated from each other and located on a surface of an insulating substrate. The plurality of first electrostatic sensing elements is spaced from each other and extends along a first direction, and the plurality of second electrostatic sensing elements is spaced from each other and extends along a second direction. Each first electrostatic sensing element and each second electrostatic sensing element includes a single walled carbon nanotube or few-walled carbon nanotube.

Abstract: The present invention provides systems and methods for improved data communication between communication terminals such as a base station and an unmanned aerial vehicle. In some instances, the systems and methods described herein provide robust transmission uplink data such as control data and wideband transmission of downlink data such as image data or other sensor data, while avoiding interference between the uplink data transmission and the downlink transmission.

Abstract: In one embodiment, an on-chip electronic-plasmonic transducer is provided that is capable of both direct plasmon generation and detection at high efficiencies. The electronic-plasmonic transducer includes a metal-insulator-metal junction formed from a first wire constructed of a first metal, a tunneling barrier material in contact with the first wire, and a second wire made from a second metal in contact with the tunneling barrier material. A plasmonic waveguide is formed as a contiguous part of the second wire, such that the waveguide is directly coupled to the MIM junction. The electronic-plasmonic transducer can both directly generate and detect plasmons, such that it may be configured on-chip as either a plasmon source or a plasmon detector. The electronic-plasmonic transducer may be used to form an on-chip plasmon-based frequency multiplier or plasmon amplifier, among other usages.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.

Abstract: The present invention is related a square packed tower for collection of flue gas CO2. The square packed tower comprises an initial absorbent distributor on the lower end of the flue gas outlet, a vertical plate packer on the lower end of the initial absorbent distributor and a radial diversion gas distributor at the bottom of the square packed tower for delivery of carbon dioxide contained in the flue gas. The radial diversion gas distributor comprises a gas inlet pipe, a butterfly base plate, a butterfly seal plate and numerous radial deflectors. The butterfly base plate is connected with outlet of the gas inlet pipe. The radial deflectors are in radial arrangement between the butterfly base plate and butterfly seal plate along the outlet of gas inlet pipe. Such square packed tower has solved such problems as low mass transfer efficiency, uneven distribution of gas phase inside the tower and high investment.

Abstract: An electrostatic sensing device comprises an electrostatic sensing module and a control unit electrically connected to the electrostatic sensing module. The electrostatic sensing module comprises a first electrostatic sensing element comprising opposite ends, and two first electrodes. The two first electrodes are separately located on and electrically connected to the two opposite ends of the first electrostatic sensing element. The first electrostatic sensing element is a single walled carbon nanotube or a few-walled carbon nanotube. The control unit electrically is configured to apply a direct voltage to the first electrostatic sensing element and measure a current/resistance of the first electrostatic sensing element.

Abstract: A method, apparatus and special phosphorus recovery device for recovering yellow phosphorus from an electric furnace phosphorus-producing furnace gas without the use of a spray cooling mode during the condensation of the electric furnace phosphorus-producing furnace gas.